These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7198496)

  • 21. Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.
    Pierga JY; Diéras V; Beuzeboc P; Dorval T; Palangié T; Jouve M; Scholl SM; Garcia-Giralt E; Pouillart P
    Gynecol Oncol; 1997 Aug; 66(2):246-9. PubMed ID: 9264570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis of follicular thyroid carcinoma (author's transl)].
    Pabst HW; Dirr W
    Schweiz Rundsch Med Prax; 1982 Mar; 71(13):555-61. PubMed ID: 7079234
    [No Abstract]   [Full Text] [Related]  

  • 23. Failure of streptozotocin in rare hormonally active malignancies.
    Weiss RB
    Cancer Treat Rep; 1978 May; 62(5):847-9. PubMed ID: 148968
    [No Abstract]   [Full Text] [Related]  

  • 24. [Aclarubicin in metastatic thyroid cancer: initial clinical experience].
    Langsteger W; Lind P; Eber O; Költringer P; Klima G
    Radiobiol Radiother (Berl); 1988; 29(2):243-5. PubMed ID: 3165198
    [No Abstract]   [Full Text] [Related]  

  • 25. [Surgical treatment of differentiated carcinoma of the thyroid. Follow-up of 99 cases].
    Pozzetto B; Roseano M; Dellach C; Leggeri A
    Chir Ital; 2000; 52(1):49-56. PubMed ID: 10832526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Calcitonin and the medullary thyroid carcinoma (author's transl)].
    Dambacher MA; Guncaga J; Heitz P; Haas HG
    Ther Umsch; 1973 Oct; 30(10):740-6. PubMed ID: 4745947
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).
    Nocera M; Baudin E; Pellegriti G; Cailleux AF; Mechelany-Corone C; Schlumberger M
    Br J Cancer; 2000 Sep; 83(6):715-8. PubMed ID: 10952773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contribution of chemotherapy in the treatment of cancer of the cavum (UCNT): apropos of 47 cases].
    Poupart M; Damiano J; Bolot G; Biron P; Caldentey L; Ardiet JM; Pignat JC
    Bull Cancer; 1994 May; 81(5):366-70. PubMed ID: 7538361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Limits and possibilities of cytostatic therapy with massive doses of cyclophosphamide].
    Chiarelli G; Garutti GP; Rambaldi P
    Arcisp S Anna Ferrara; 1967; 20(3):385-400. PubMed ID: 5606860
    [No Abstract]   [Full Text] [Related]  

  • 30. [Histomorphological investigations of endometrial carcinoma during progestional treatment with chlormadione acetate (author's transl)].
    Boquoi E; Kreuzer G
    Geburtshilfe Frauenheilkd; 1973 Sep; 33(9):697-708. PubMed ID: 4129072
    [No Abstract]   [Full Text] [Related]  

  • 31. Intensive chemotherapy for anaplastic thyroid carcinoma: combination of cisplatin, doxorubicin, etoposide and peplomycin with granulocyte granulocyte colony-stimulating factor support. Chemotherapy Committee, The Japanese Society of Thyroid Surgery.
    Jpn J Clin Oncol; 1995 Oct; 25(5):203-7. PubMed ID: 7474408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Undifferentiated carcinoma of the thyroid gland].
    Busnardo B; Girelli ME; Nacamulli D; Pelizzo MR; Daniele O; Rigon A
    Chir Ital; 1994; 46(4):37-41. PubMed ID: 7533667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Our experience with total thyroidectomy in the treatment of differentiated carcinomas of the thyroid].
    Balanzoni S; Poddie D; Stancanelli V
    Minerva Med; 1980 Jun; 71(23):1639-42. PubMed ID: 7383415
    [No Abstract]   [Full Text] [Related]  

  • 34. [Etoposide, pirarubicin and cisplatin(ETP) combined therapy of inoperable head and neck cancer].
    Kawakami T; Watanabe S; Ogawara T; Akagi S; Tamura S; Koide I; Ogawa A; Takiguchi S; Masuda Y
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):669-72. PubMed ID: 8470928
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of metastatic medullary thyroid gland carcinoma with the somatostatin analog octreotide].
    Frank-Raue K; Raue F; Ziegler R
    Med Klin (Munich); 1995 Feb; 90(2):63-6. PubMed ID: 7708002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy.
    Greco FA; Hainsworth JD
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):77-82. PubMed ID: 7992071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serum thyroglobulin (S-hTG): a tumor marker in patients with differentiated thyroid carcinoma (author's transl)].
    Jänsch A; Heinze HG; Hast B
    Strahlentherapie; 1981 Jun; 157(6):381-92. PubMed ID: 7256806
    [No Abstract]   [Full Text] [Related]  

  • 38. An attempt at influencing thyroid carcinoma with hormones.
    Tesárek T
    Neoplasma; 1974; 21(3):331-4. PubMed ID: 4424952
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral blindness in association with cis-platinum chemotherapy for advanced carcinoma of the fallopian tube.
    Diamond SB; Rudolph SH; Lubicz SS; Deppe G; Cohen CJ
    Obstet Gynecol; 1982 Jun; 59(6 Suppl):84S-6S. PubMed ID: 7201125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.